Prognostic features and comprehensive genomic analysis of <scp> <i>NF1</i> </scp> mutations in <scp> <i>EGFR</i> </scp> mutant lung cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients

Published:2022-06-14 Issue:1 Volume:12 Page:396-406
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Tian Hong‐xia¹²^ORCID,Chen Zhi‐hong¹²,Jie Guang‐Ling¹,Wang Zhen¹²,Yan Hong‐hong¹²,Wu Si‐pei¹²,Zhang Shui‐lian¹²,Lu Dan‐xia¹²,Zhang Xu‐chao¹²,Wu Yi‐long¹²^ORCID

Affiliation:

1. Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China

2. Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4925

Reference30 articles.

1. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

2. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1);Cancers;2023-09-15

2. Prognosis of early‐stage lung adenocarcinoma in young patients;Clinical and Experimental Pharmacology and Physiology;2023-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP